Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIOLIFE SOLUTIONS INCBLFS · Entity 4614 | Chief Revenue Officer | May 28, 2020 | June 02, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIOLIFE SOLUTIONS INC
Report date May 28, 2020 · Filed June 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,856 |
Reported balance
After 2020-05-28 transaction · row 1
1 source rowRow 1 · 2020-05-28 · Sale · Disposed 121 · Balance 19,856 F1: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 28, 2020 Filed Jun 2, 2020 00:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 121 | $16.87 | $2,041.27 |
DisclosureSEC source: 0001437749-20-012244 · rdgdoc.xml · nonDerivative · entry 1 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,856 F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| March 25, 2020 Filed Mar 28, 2020 01:57 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 3,101 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-20-006394 · rdgdoc.xml · nonDerivative · entry 1 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,977 F1 · security: The restricted stock pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests in full on September 25, 2020. This restricted stock was granted to the reporting person in lieu of such reporting person's 2019 cash performance bonus. F1 · price: The restricted stock pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests in full on September 25, 2020. This restricted stock was granted to the reporting person in lieu of such reporting person's 2019 cash performance bonus. Read SEC document |
| February 26, 2020 Filed Feb 29, 2020 01:14 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 508 | $15.02 | $7,630.16 |
DisclosureSEC source: 0001437749-20-004027 · rdgdoc.xml · nonDerivative · entry 1 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,876 F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 04, 2020 Filed Feb 7, 2020 01:45 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,113 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-20-001950 · rdgdoc.xml · derivative · entry 3 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,113 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: The reporting person's Form 4 filed on January 23, 2019 reported a remainder of 2,613 derivative securities when in fact the remainder was 2,113 derivative securities beneficially owned by the reporting person. Read SEC document |
| February 04, 2020 Filed Feb 7, 2020 01:45 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,113 | $14.03 | $29,645.39 |
DisclosureSEC source: 0001437749-20-001950 · rdgdoc.xml · nonDerivative · entry 2 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.01 to $14.03, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 04, 2020 Filed Feb 7, 2020 01:45 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,113 | $1.64 | $3,465.32 |
DisclosureSEC source: 0001437749-20-001950 · rdgdoc.xml · nonDerivative · entry 1 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2020 Filed Jan 24, 2020 01:05 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-20-001098 · rdgdoc.xml · derivative · entry 9 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,613 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2020 Filed Jan 24, 2020 01:05 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $15.11 | $37,775.00 |
DisclosureSEC source: 0001437749-20-001098 · rdgdoc.xml · nonDerivative · entry 6 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.10 to $15.11, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 23, 2020 Filed Jan 24, 2020 01:05 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-20-001098 · rdgdoc.xml · nonDerivative · entry 5 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 01:05 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-20-001098 · rdgdoc.xml · derivative · entry 8 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,113 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 01:05 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $15.68 | $39,200.00 |
DisclosureSEC source: 0001437749-20-001098 · rdgdoc.xml · nonDerivative · entry 4 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 01:05 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-20-001098 · rdgdoc.xml · nonDerivative · entry 3 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 24, 2020 01:05 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-20-001098 · rdgdoc.xml · derivative · entry 7 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,613 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 21, 2020 Filed Jan 24, 2020 01:05 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $15.69 | $39,225.00 |
DisclosureSEC source: 0001437749-20-001098 · rdgdoc.xml · nonDerivative · entry 2 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.56 to $15.82, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 21, 2020 Filed Jan 24, 2020 01:05 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-20-001098 · rdgdoc.xml · nonDerivative · entry 1 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2020 Filed Jan 10, 2020 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-20-000418 · rdgdoc.xml · derivative · entry 9 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,113 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 09, 2020 Filed Jan 10, 2020 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $16.76 | $41,900.00 |
DisclosureSEC source: 0001437749-20-000418 · rdgdoc.xml · nonDerivative · entry 6 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. Read SEC document |
| January 09, 2020 Filed Jan 10, 2020 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-20-000418 · rdgdoc.xml · nonDerivative · entry 5 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-20-000418 · rdgdoc.xml · derivative · entry 8 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,613 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $16.05 | $40,125.00 |
DisclosureSEC source: 0001437749-20-000418 · rdgdoc.xml · nonDerivative · entry 4 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.09, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 08, 2020 Filed Jan 10, 2020 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-20-000418 · rdgdoc.xml · nonDerivative · entry 3 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2020 Filed Jan 10, 2020 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-20-000418 · rdgdoc.xml · derivative · entry 7 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,113 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2020 Filed Jan 10, 2020 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $15.73 | $39,325.00 |
DisclosureSEC source: 0001437749-20-000418 · rdgdoc.xml · nonDerivative · entry 2 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.55 to $15.78, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 07, 2020 Filed Jan 10, 2020 01:01 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-20-000418 · rdgdoc.xml · nonDerivative · entry 1 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2019 Filed Dec 28, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-024973 · rdgdoc.xml · derivative · entry 9 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,613 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2019 Filed Dec 28, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $16.61 | $41,525.00 |
DisclosureSEC source: 0001437749-19-024973 · rdgdoc.xml · nonDerivative · entry 6 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. Read SEC document |
| December 27, 2019 Filed Dec 28, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-024973 · rdgdoc.xml · nonDerivative · entry 5 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 26, 2019 Filed Dec 28, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-024973 · rdgdoc.xml · derivative · entry 8 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,113 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 26, 2019 Filed Dec 28, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $16.51 | $41,275.00 |
DisclosureSEC source: 0001437749-19-024973 · rdgdoc.xml · nonDerivative · entry 4 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $16.54, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 26, 2019 Filed Dec 28, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-024973 · rdgdoc.xml · nonDerivative · entry 3 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 24, 2019 Filed Dec 28, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-024973 · rdgdoc.xml · derivative · entry 7 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,613 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 24, 2019 Filed Dec 28, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $16.40 | $41,000.00 |
DisclosureSEC source: 0001437749-19-024973 · rdgdoc.xml · nonDerivative · entry 2 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. Read SEC document |
| December 24, 2019 Filed Dec 28, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-024973 · rdgdoc.xml · nonDerivative · entry 1 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 02:17 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-024354 · rdgdoc.xml · derivative · entry 9 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,113 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 02:17 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $15.00 | $37,500.00 |
DisclosureSEC source: 0001437749-19-024354 · rdgdoc.xml · nonDerivative · entry 6 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.99 to $15.00, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 02:17 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-024354 · rdgdoc.xml · nonDerivative · entry 5 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 02:17 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-024354 · rdgdoc.xml · derivative · entry 8 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,613 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 02:17 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $15.08 | $37,700.00 |
DisclosureSEC source: 0001437749-19-024354 · rdgdoc.xml · nonDerivative · entry 4 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.04 to $15.24, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 02:17 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-024354 · rdgdoc.xml · nonDerivative · entry 3 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2019 Filed Dec 13, 2019 02:17 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-024354 · rdgdoc.xml · derivative · entry 7 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,113 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2019 Filed Dec 13, 2019 02:17 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $15.65 | $39,125.00 |
DisclosureSEC source: 0001437749-19-024354 · rdgdoc.xml · nonDerivative · entry 2 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.54 to $15.68, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 10, 2019 Filed Dec 13, 2019 02:17 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-024354 · rdgdoc.xml · nonDerivative · entry 1 Mathers James · CIK 0001676166 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2019 Filed Nov 30, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-023718 · rdgdoc.xml · derivative · entry 9 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,613 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2019 Filed Nov 30, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $16.33 | $40,825.00 |
DisclosureSEC source: 0001437749-19-023718 · rdgdoc.xml · nonDerivative · entry 6 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.26 to $16.40, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range Read SEC document |
| November 29, 2019 Filed Nov 30, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-023718 · rdgdoc.xml · nonDerivative · entry 5 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2019 Filed Nov 30, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-023718 · rdgdoc.xml · derivative · entry 8 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,113 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 27, 2019 Filed Nov 30, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $16.27 | $40,675.00 |
DisclosureSEC source: 0001437749-19-023718 · rdgdoc.xml · nonDerivative · entry 4 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.23 to $16.30, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 27, 2019 Filed Nov 30, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 2,500 | $1.64 | $4,100.00 |
DisclosureSEC source: 0001437749-19-023718 · rdgdoc.xml · nonDerivative · entry 3 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2019 Filed Nov 30, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionEmployee Stock Option · Derivative | 2,500 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-19-023718 · rdgdoc.xml · derivative · entry 7 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,613 Underlying: Common Stock · 2,500 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2019 Filed Nov 30, 2019 01:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 2,500 | $16.52 | $41,300.00 |
DisclosureSEC source: 0001437749-19-023718 · rdgdoc.xml · nonDerivative · entry 2 Mathers James · CIK 0001676166 · Vice President, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $16.56, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.